We are live on ! Find out more
EVM

Eaton Vance Management Portfolio holdings

AUM $67.5B
1-Year Est. Return 11.44%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
-11.44%
3 Year Est. Return
+49.6%
5 Year Est. Return
+94.25%
10 Year Est. Return
AUM
$33B
AUM Growth
Cap. Flow
+$33B
Cap. Flow %
100.13%
Top 10 Hldgs %
18.52%
Holding
828
New
828
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$713M
2
WFC icon
Wells Fargo
WFC
+$710M
3
DIS icon
Walt Disney
DIS
+$624M
4
PFE icon
Pfizer
PFE
+$615M
5
CVX icon
Chevron
CVX
+$593M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 12.55%
3 Technology 12.44%
4 Industrials 11.99%
5 Energy 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
101
Philip Morris
PM
$317B
$90.7M 0.28%
+1,047,371
New +$97.3M
BRK.A icon
102
Berkshire Hathaway Class A
BRK.A
$1.09T
$88.7M 0.27%
+526
New +$86.8M
BEN icon
103
Franklin Resources
BEN
$17.3B
$85.5M 0.26%
+1,885,143
New +$96M
GLW icon
104
Corning
GLW
$103B
$82.8M 0.25%
+5,821,860
New +$84.7M
ITW icon
105
Illinois Tool Works
ITW
$85.7B
$82.2M 0.25%
+1,188,585
New +$79.5M
ETN icon
106
Eaton
ETN
$150B
$81.6M 0.25%
+1,240,079
New +$78.2M
STT icon
107
State Street
STT
$49.9B
$81.2M 0.25%
+1,244,722
New +$77.4M
BMY icon
108
Bristol-Myers Squibb
BMY
$130B
$76.9M 0.23%
+1,720,728
New +$74.7M
SHPG
109
DELISTED
Shire pic
SHPG
$76.3M 0.23%
+801,723
New +$75.2M
SNY icon
110
Sanofi
SNY
$108B
$75.6M 0.23%
+1,467,928
New +$78.2M
TEVA icon
111
Teva Pharmaceuticals
TEVA
$36.4B
$74.5M 0.23%
+1,899,944
New +$74M
LOW icon
112
Lowe's Companies
LOW
$122B
$74.4M 0.23%
+1,819,185
New +$73.2M
FCX icon
113
Freeport-McMoran
FCX
$89B
$73.1M 0.22%
+2,648,324
New +$80.8M
ECL icon
114
Ecolab
ECL
$79.3B
$72.5M 0.22%
+851,426
New +$71.9M
EV
115
DELISTED
Eaton Vance Corp.
EV
$72.3M 0.22%
+1,922,261
New +$77.3M
BHP icon
116
BHP
BHP
$213B
$71M 0.22%
+1,455,425
New +$80.7M
ADI icon
117
Analog Devices
ADI
$181B
$69.1M 0.21%
+1,534,174
New +$69.1M
NVO
118
Novo Nordisk
NVO
$225B
$64.7M 0.2%
+4,177,360
New +$69.5M
ESRX
119
DELISTED
Express Scripts Holding Company
ESRX
$60.8M 0.18%
+985,150
New +$59.3M
CMCSK
120
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$59.9M 0.18%
+1,510,610
New +$59.9M
SCHW
121
Charles Schwab
SCHW
$184B
$59.1M 0.18%
+2,783,401
New +$51.4M
LLY icon
122
Eli Lilly
LLY
$1.09T
$57.9M 0.18%
+1,178,175
New +$64.1M
TROW icon
123
T. Rowe Price
TROW
$26B
$50M 0.15%
+683,076
New +$51M
CYT
124
DELISTED
CYTEC INDS INC
CYT
$45.6M 0.14%
+1,244,564
New +$45.5M
UPS icon
125
United Parcel Service
UPS
$90.6B
$45.4M 0.14%
+525,111
New +$45M

Similar funds

Eaton Vance Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Eaton Vance Management, which disclosed 828 positions worth $33B. Its ten largest holdings account for 19% of the portfolio.

Its largest position is JPMorgan Chase: 14,028,181 shares worth $741M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, followed by Healthcare and Technology.

  • Eaton Vance Management's largest Q2 2013 buy was JPMorgan Chase: 14,028,181 shares worth $741M.
  • Eaton Vance Management's ten largest holdings make up 19% of its $33B portfolio in Q2 2013.
  • Eaton Vance Management disclosed 828 positions in Q2 2013, its first 13F filing on record.

Based on Eaton Vance Management's 13F filing for Q2 2013, filed 14 Aug 2013.